Contrast Media Market Report Size, Share, Growth, Trends and Analysis 2024-2032 | Bayer AG (Germany), Bracco Diagnostic Inc

Global Contrast Media Market Size, Status, and forecast for the 2025-2032. The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Contrast Media Market industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. Additionally, the report includes upstream and downstream analyses of key players, as well as global certainties and assurances. The report evaluates dynamic aspects such as forecast market information, Porter's Five Forces Analysis, sales estimates, wide product portfolio, market scenarios, and possibility studies.

The global contrast media market size was estimated at USD 6.29 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 7.99% from 2025 to 2032.

Updated Version of Sample Report Included:
https://www.marketdigits.com/request/sample/4201

Contrast Media Market Drivers:

Globally, there has been a significant increase in the number of people suffering from cancer. In various countries across the globe, people are adopting a sedentary lifestyle, which is characterized by a high-calorie diet (that is rich in fat, refined carbohydrates, and animal protein) and low physical activity. With such changes in lifestyle, the number of people suffering from cancer is expected to increase.Over the years, the prevalence of chronic diseases such as cardiovascular disease (CVD) and cancer has increased significantly. Some key statistics in this regard have been mentioned below:According to an article published by the Pan American Health Organization (PAHO), globally, there were 20 million new cancer cases and 10 million cancer deaths. Projections indicate a projected 60% increase in the cancer burden over the next two decades. The anticipated worldwide burden is set to rise to around 30 million new cancer cases by 2040, with the most significant increases expected in low- and middle-income countries.According to estimates from the International Agency for Research on Cancer (IARC), globally, new cancer cases are expected to grow to 27.5 million, and 16.3 million cancer deaths are expected to occur due to the growing population by 2040.

Contrast Media Market Restraint:

Contrast media are generally considered safe to use for various diagnostic procedures, such as MRI and CT scans. However, their use might be limited in certain patients due to side effects and allergic reactions, which can hinder the growth of the market to a certain extent. Their adverse reactions range from mild to severe; however, severe reactions are very uncommon, and severe allergic responses to contrast materials are rare. For instance, as per an article published by the NIH, the incidence of immediate reactions to nonionic contrast media ranges from 0.01-0.04% (severe) to 3% (mild). Nonionic agents are associated with a decreased risk of adverse reactions.

Contrast Media Market Opportunity:

Rising R&D into novel contrast media, as well as the development of newer applications of contrast media, provide immense opportunities for market players. Companies, research institutes, and universities across the globe are undertaking projects to develop novel contrast media and expand their applications. In October 2022, researcher Stefan Glöggler devised an effective contrast agent technique for MRI, potentially enabling the differentiation between tumors and healthy tissue based on their metabolic activity. The ForTra GmbH für Forschungstransfer of the Else Kröner-Fresenius Foundation (ForTra) and the European Research Council (ERC) are now offering financial support to advance this method for clinical patient trials. Similarly, in 2020, a biochemistry and pharmacology professor, Dr. Gang Han, received USD 25,000 in seed funding from the UMass Technology Development Fund for research on MRI contrast media or gadolinium-based agents with fewer adverse effects.

Major Players in Contrast Media Markets are:

Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.)

Industry News:

In April 2023, GE HealthCare expanded its contrast media portfolio by introducing Pixxoscan (gadobutrol), a macrocyclic, non-ionic magnetic resonance imaging (MRI) gadolinium-based contrast agent (GBCA). Pixxoscan underwent regulatory review via a decentralized procedure (DCP), securing marketing authorization in Austria.

In September 2022, The company received FDA approval for the VUEWAY Gadopiclenol contrast media injection for use in adult and pediatric patients aged two years and older during magnetic resonance imaging (MRI) scans.
In December 2021, Bracco Diagnostics entered into a collaboration agreement with Guerbet for the production and research related to Gadopiclenol, a high-relaxivity macrocyclic contrast agent.

In March 2021, Guerbet and Bracco Imaging entered into a global strategic collaboration agreement for Gadopiclenol. The companies will collaborate on manufacturing, research, and development for potential future indications. Upon regulatory approval, they will independently commercialize Gadopiclenol, an investigational GBCA, under separate brands.

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

Global Contrast Media Market Segmentation:

By Modality Outlook
Ultrasound
Magnetic Resonance Imaging
X-ray/Computed Tomography

By Product Outlook
Microbubble
Gadolinium-Based
Iodinated
Barium-Based

By Application Outlook
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Others

By Route Of Administration Outlook
Intravenous
Oral Route
Rectal Route
End-use Outlook
Hospitals
Diagnostic Imaging Centers
Others

Know more about this report:
https://www.marketdigits.com/contrast-media-market-1708610489

The following areas and countries are covered in the worldwide Contrast Media Market file:

North America (US, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE), Egypt, Nigeria, and South Korea)

In 2023, North America emerged as the leading contributor, accounting for the largest share of the market. With the presence of major players in the region, the region has witnessed an increase in the number of product approvals. These companies based in North America have expertise, resources, and well-established sales networks, contributing to the region's market dominance.

Detailed industry forecast-Brief Introduction to the research report:

Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

Discover More: Visit Our Website for Additional Reports!

https://www.marketdigits.com/flying-car-market-1694177145

https://www.marketdigits.com/cranes-market-1694177145

https://www.marketdigits.com/automotive-robotics-market-1694177145

https://www.marketdigits.com/aircraft-carbon-brake-disc-market-1694177145

https://www.marketdigits.com/automotive-antifreeze-market-1694177145

About Us

Founded in 2015, MarketDigits Consulting & Advisory Pvt Ltd is a leading business research and consulting firm. Our mission is to empower clients by identifying emerging opportunities and driving revenue growth across industries. We specialize in providing comprehensive market insights, advanced technology solutions, and actionable strategies that support operational and strategic decision-making.

With a focus on the full value chain, our expert team delivers high-quality syndicate research reports, proprietary databases, and consulting services to help clients navigate today's competitive and dynamic business environment. At MarketDigits, we use advanced analysis to uncover profitable opportunities, enabling businesses to make smart decisions and achieve sustainable success.

Contact Us:

+1 510-730-3200 | +1 276-206-2055

sales@marketdigits.com

1248 CarMia Way Richmond

VA 23235, United States

This release was published on openPR.